Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Disease 2019

Wagner, Darcy E LU orcid ; Ikonomou, Laertis ; Gilpin, Sarah E ; Magin, Chelsea M ; Cruz, Fernanda ; Greaney, Allison ; Magnusson, Mattias LU ; Chen, Ya-Wen ; Davis, Brian and Vanuytsel, Kim , et al. (2020) In ERJ Open Research 6(4).
Abstract

A workshop entitled "Stem Cells, Cell Therapies and Bioengineering in Lung Biology and Diseases" was hosted by the University of Vermont Larner College of Medicine in collaboration with the National Heart, Lung and Blood Institute, the Alpha-1 Foundation, the Cystic Fibrosis Foundation, the International Society for Cell and Gene Therapy and the Pulmonary Fibrosis Foundation. The event was held from July 15 to 18, 2019 at the University of Vermont, Burlington, Vermont. The objectives of the conference were to review and discuss the current status of the following active areas of research: 1) technological advancements in the analysis and visualisation of lung stem and progenitor cells; 2) evaluation of lung stem and progenitor cells in... (More)

A workshop entitled "Stem Cells, Cell Therapies and Bioengineering in Lung Biology and Diseases" was hosted by the University of Vermont Larner College of Medicine in collaboration with the National Heart, Lung and Blood Institute, the Alpha-1 Foundation, the Cystic Fibrosis Foundation, the International Society for Cell and Gene Therapy and the Pulmonary Fibrosis Foundation. The event was held from July 15 to 18, 2019 at the University of Vermont, Burlington, Vermont. The objectives of the conference were to review and discuss the current status of the following active areas of research: 1) technological advancements in the analysis and visualisation of lung stem and progenitor cells; 2) evaluation of lung stem and progenitor cells in the context of their interactions with the niche; 3) progress toward the application and delivery of stem and progenitor cells for the treatment of lung diseases such as cystic fibrosis; 4) progress in induced pluripotent stem cell models and application for disease modelling; and 5) the emerging roles of cell therapy and extracellular vesicles in immunomodulation of the lung. This selection of topics represents some of the most dynamic research areas in which incredible progress continues to be made. The workshop also included active discussion on the regulation and commercialisation of regenerative medicine products and concluded with an open discussion to set priorities and recommendations for future research directions in basic and translation lung biology.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
ERJ Open Research
volume
6
issue
4
publisher
European Respiratory Society
external identifiers
  • pmid:33123557
  • scopus:85109494368
ISSN
2312-0541
DOI
10.1183/23120541.00123-2020
language
English
LU publication?
yes
additional info
Copyright ©ERS 2020.
id
1411d214-1311-4cc8-a99e-34638dad98d8
date added to LUP
2020-11-02 16:38:28
date last changed
2024-05-01 08:58:24
@article{1411d214-1311-4cc8-a99e-34638dad98d8,
  abstract     = {{<p>A workshop entitled "Stem Cells, Cell Therapies and Bioengineering in Lung Biology and Diseases" was hosted by the University of Vermont Larner College of Medicine in collaboration with the National Heart, Lung and Blood Institute, the Alpha-1 Foundation, the Cystic Fibrosis Foundation, the International Society for Cell and Gene Therapy and the Pulmonary Fibrosis Foundation. The event was held from July 15 to 18, 2019 at the University of Vermont, Burlington, Vermont. The objectives of the conference were to review and discuss the current status of the following active areas of research: 1) technological advancements in the analysis and visualisation of lung stem and progenitor cells; 2) evaluation of lung stem and progenitor cells in the context of their interactions with the niche; 3) progress toward the application and delivery of stem and progenitor cells for the treatment of lung diseases such as cystic fibrosis; 4) progress in induced pluripotent stem cell models and application for disease modelling; and 5) the emerging roles of cell therapy and extracellular vesicles in immunomodulation of the lung. This selection of topics represents some of the most dynamic research areas in which incredible progress continues to be made. The workshop also included active discussion on the regulation and commercialisation of regenerative medicine products and concluded with an open discussion to set priorities and recommendations for future research directions in basic and translation lung biology.</p>}},
  author       = {{Wagner, Darcy E and Ikonomou, Laertis and Gilpin, Sarah E and Magin, Chelsea M and Cruz, Fernanda and Greaney, Allison and Magnusson, Mattias and Chen, Ya-Wen and Davis, Brian and Vanuytsel, Kim and Rolandsson Enes, Sara and Krasnodembskaya, Anna and Lehmann, Mareike and Westergren-Thorsson, Gunilla and Stegmayr, John and Alsafadi, Hani N and Hoffman, Evan T and Weiss, Daniel J and Ryan, Amy L}},
  issn         = {{2312-0541}},
  language     = {{eng}},
  number       = {{4}},
  publisher    = {{European Respiratory Society}},
  series       = {{ERJ Open Research}},
  title        = {{Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Disease 2019}},
  url          = {{http://dx.doi.org/10.1183/23120541.00123-2020}},
  doi          = {{10.1183/23120541.00123-2020}},
  volume       = {{6}},
  year         = {{2020}},
}